🧪 UPDATED DAILY FROM CLINICALTRIALS.GOVSynced today

Find Clinical Trials for Your Rare Disease

10452+ recruiting trials across all rare diseases. Filter by phase, location, and condition.

Clinical trial records are synced from ClinicalTrials.gov.
Report missing data

Showing 20 of 10452 recruiting trials

NARecruitingNCT06854627

Effect of Continuous Prolonged Prone Position Versus Intermittent Daily Prone Position in ARDS

👨‍⚕️ Alejandro Bruhn, MD, PhD, Pontifiia Universidad Catolica de Chile📍 6 sites📅 Started Apr 2025View details ↗
NARecruitingNCT06884423

Safety and Efficacy of FETO in CDH: A Phase III Trial

👨‍⚕️ Holly L Hedrick, MD, FACS, Children's Hospital of Philadelphia📍 2 sites📅 Started Apr 2025View details ↗
Phase 1, PHASE2RecruitingNCT06892678

DFMO Maintenance for Patients With Relapsed/Refractory Ewing Sarcoma or Osteosarcoma

👨‍⚕️ Alice Lee, MD, Montefiore Medical Center📍 1 site📅 Started Apr 2025View details ↗
Phase 1RecruitingNCT06934889

Study of ABBV-637 or ABBV-155 With ERAS-801 for People With Glioblastoma

👨‍⚕️ Thomas Kaley, MD, Memorial Sloan Kettering Cancer Center📍 10 sites📅 Started Apr 2025View details ↗
NARecruitingNCT07112703

Effect of Incentive Respiratory Training on Pulmonary Functions and Functional Capacity in Children With B-thalassemia Major

🏥 Rawan Mohammed Khairy Mostafa Elsawy📍 1 site📅 Started Apr 2025View details ↗
NARecruitingNCT06928233

Association of TNFAIP3 With Immune-mediated TTP

👨‍⚕️ Ilaria Mancini, PhD, Fondazione IRCCS Ca' Granda, Ospedale Maggiore Policlinico📍 1 site📅 Started Apr 2025View details ↗
Phase 1RecruitingNCT06834282

CER-1236 in Patients With Acute Myeloid Leukemia (AML), Myelodysplastic Syndrome (MDS), and Myelofibrosis (MF)

🏥 CERo Therapeutics Holdings, Inc.📍 4 sites📅 Started Apr 2025View details ↗
Phase 1RecruitingNCT06773481

BC008-1A Injection for Recurrent CNS WHO G4 Glioma

🏥 Sichuan Luzhou Buchang Biopharmaceutical Co., Ltd.📍 1 site📅 Started Apr 2025View details ↗
EARLY_Phase 1RecruitingNCT06610682

Feasibility of CSF and Plasma ctDNA in BRAF-altered Glioma During Treatment With Plixorafenib

👨‍⚕️ Karisa Schreck, MD, Johns Hopkins University📍 1 site📅 Started Apr 2025View details ↗
Phase 1RecruitingNCT06714006

Phase 1 Study to Evaluate the Safety and Tolerability of Intravenously Administered PYC-003

🏥 PYC Therapeutics📍 9 sites📅 Started Apr 2025View details ↗
Phase 1RecruitingNCT06924385

Safety, Tolerability, and PK/PD of Telpegfilgrastim Injection in Non-pregnant Females of Childbearing

👨‍⚕️ Yuan Wei, Ph.D, Peking University Third Hospital📍 1 site📅 Started Apr 2025View details ↗
NARecruitingNCT06994754

Evaluation of Maxillary Expansion Using Clear Aligners' Therapy in Patients With Cleft Lip and Palate at the Mixed Dentition Stage

🏥 Cairo University📍 1 site📅 Started Apr 2025View details ↗
NARecruitingNCT06902844

Equecabtagene Autoleucel Injection (Eque-cel) for Relapsed/Refractory Systemic Lupus Erythematosus (SLE)

🏥 Tongji Hospital📍 1 site📅 Started Apr 2025View details ↗
Phase 2RecruitingNCT06912074

Hypofractionated vs. Conventional Chemoradiotherapy After Induction Chemo-immunotherapy for Unresectable Esophageal Squamous Cell Carcinoma

👨‍⚕️ Hui Liu, Professor, Sun yat-sen universtiy cancer center📍 1 site📅 Started Apr 2025View details ↗
NARecruitingNCT07430098

Feedback-Based Balance Training for Adolescents With Idiopathic Scoliosis

🏥 Ankara Etlik City Hospital📍 1 site📅 Started Apr 2025View details ↗
NARecruitingNCT06840587

Connect-Home: Alzheimer's Disease and Related Dementias

👨‍⚕️ Mark Toles, PhD, RN, University of North Carolina, Chapel Hill📍 1 site📅 Started Apr 2025View details ↗
Phase 2Enrolling by InvitationNCT06971900

GATEWAY: A Phase 2a Study of PORT-77 in Adults With Erythropoietic Protoporphyria

👨‍⚕️ Chief Medical Officer, Portal Therapeutics, Inc.📍 1 site📅 Started Apr 2025View details ↗
RecruitingNCT06928727

Ocular Characteristics in Patients With Craniosynostosis

🏥 Centre Hospitalier Universitaire, Amiens📍 1 site📅 Started Apr 2025View details ↗
Phase 1RecruitingNCT06523699

Impact of Recombinant Human Interleukin-7 (CYT107) on Tumor Clearance and Immune Reconstitution in Multiple Myeloma Patients After Autologous Hematopoietic Cell Transplant

👨‍⚕️ Dilan A Patel, M.D., Washington University School of Medicine📍 1 site📅 Started Apr 2025View details ↗
Phase 4RecruitingNCT06865885

LDL-C Optimization Using Inclisiran in Patients in Which Drug-Drug Interactions Limit LDL Lowering

👨‍⚕️ Michael Wilkinson, MD, University of California, San Diego📍 1 site📅 Started Apr 2025View details ↗
← PreviousPage 126 of 523Next →

Get alerts when new trials open

Create a free account to follow conditions and receive trial notifications.

Create free account →